Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma

NCT00916058 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bendamustine
DRUG: Melphalan
DRUG: Bendamustine
DRUG: Bendamustine
DRUG: Bendamustine
DRUG: Bendamustine
DRUG: Bendamustine

Sponsor

Weill Medical College of Cornell University